Ferriman-Gallwey Scores, Serum Androgen and Mullerian Inhibiting Substance Levels in Hirstute Adolescent Girls

Journal of Pediatric and Adolescent Gynecology

Volumn 25, Issue 5, 2012, Pages 300-304

  Hertweck, S P ^a   Yoost, J L ^a   McClure, M E ^a   Siow, Y ^a   Brock, G N ^a   Wintergerst, K A ^a   Fallat, M E ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Adolescent gynecology; Ferriman Gallwey; Hirsutism; Mullerian inhibiting substance

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; FOLLITROPIN; HYDROCORTISONE; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; PROLACTIN; TESTOSTERONE;

ADOLESCENT; ADULT; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; FERRIMAN GALLWEY SCORE; FOLLITROPIN BLOOD LEVEL; HIRSUTISM; HUMAN; HYDROCORTISONE BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SCHOOL CHILD; SCORING SYSTEM; TESTOSTERONE BLOOD LEVEL; UNIVERSITY HOSPITAL;

ADOLESCENT; ANDROGENS; ANTI-MULLERIAN HORMONE; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HIRSUTISM; HUMANS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84866268819     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2012.05.002     Document Type: Article

References (22)

1. Ferriman D., Gallwey J.D. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961, 21:1440.
2. Knochenhauer E.S., Key T.J., Kahsar-Miller M., et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998, 83:3078.
3. Hassa H., Tanir H.M., Yildirim A., et al. The hirsutism scoring system should be population specific. Fertil Steril 2005, 84:778.
4. Ewing J.A., Rouse B.A. Hirsutism, race and testosterone levels: comparison of East Asians and Euroamericans. Hum Biol 1978, 50:209.
5. Drosdzol A., Skrzypulec V., Plinta R. Quality of life, mental health and self-esteem in hirsute adolescent females. J Psychosom Obstet Gynaecol 2010, 31:168.
6. Azziz R., Carmina E., Sawaya M.E. Idiopathic hirsutism. Endocr Rev 2000, 21:347.
7. Rittmaster R.S. Hirsutism. Lancet 1997, 349:191.
8. Lee M.M., Donahoe P.K. Mullerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 1993, 14:152.
9. Fallat M.E., Siow Y., Marra M., et al. Müllerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis. Fertil Steril 1997, 67:962.
10. Tanner J.M., Whitehouse R.H. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976, 51:170.
11. Wild R.A., Vesely S., Beebe L., et al. Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005, 90:4112.
12. Api M., Badoglu B., Akca A., et al. Interobserver variability of modified Ferriman-Gallwey hirsutism score in a Turkish population. Arch Gynecol Obstet 2009, 279:473.
13. DeUgarte C.M., Woods K.S., Bartolucci A.A., et al. Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab 2006, 91:1345.
14. Mueller A., Cupisti S., Binder H., et al. Endocrinological markers for assessment of hyperandrogenemia in hirsute women. Horm Res 2007, 67:35.
15. Cross G., Danilowicz K., Kral M., et al. Sex hormone binding globulin decrease as a potential pathogenetic factor for hirsutism in adolescent girls. Medicina (B Aires) 2008, 68:120.
16. Willenberg H.S., Bahlo M., Schott M., et al. Helpful diagnostic markers of steroidogenesis for defining hyperandrogenemia in hirsute women. Steroids 2008, 73:41.
17. Sagsoz N., Kamaci M., Orbak Z. Body hair scores and total hair diameters in healthy women in the Kirikkale Region of Turkey. Yonsei Med J 2004, 45:483.
18. Cook C.L., Siow Y., Brenner A.G., et al. Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil Steril 2002, 77:141.
19. Siow Y., Kives S., Hertweck P., et al. Serum Mullerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome. Fertil Steril 2005, 84:938.
20. Lin Y.H., Chiu W.C., Wu C.H., et al. Antimullerian hormone and polycystic ovary syndrome. Fertil Steril 2011, 96:230.
21. Cosar E., Koken G., Sahin F.K., et al. Insulin sensitivity does not differentiate by hirsutism in non-obese women with polycystic ovary syndrome. Endocr J 2008, 55:465.
22. Carmina E., Oberfield S.E., Lobo R.A. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol 2010, 203:201.e1.